The Dynamic Duo for Cardiac Diabetic Management
Introducing DAPOCEE M Forte Tablets In the realm of cardiac diabetic management, precision and efficacy are paramount. Meet DAPOCEE M Forte Tablets, the latest offering from the Cardix Life Care division of Fibovil Pharmaceuticals. These tablets are meticulously crafted to address the intricate needs of individuals battling cardiac diabetes, providing a potent combination of Dapagliflozin 10mg and Metformin Hydrochloride I.P. 1000mg in each dose. The Power of Combination: DAPOCEE M Forte Tablets harness the synergistic effects of Dapagliflozin and Metformin Hydrochloride to offer comprehensive management of cardiac diabetes. Dapagliflozin, a highly selective SGLT2 inhibitor, works by promoting urinary glucose excretion, thereby reducing blood glucose levels. Metformin Hydrochloride, on the other hand, enhances insulin sensitivity and decreases hepatic glucose production, further aiding in glycemic control. Together, they form a formidable duo that targets multiple facets of di...